Cim Investment Management Inc Reata Pharmaceuticals Inc Transaction History

Cim Investment Management Inc

  • $332 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$100.0 - $143.02 $164,800 - $235,696
-1,648 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$78.27 - $151.29 $128,988 - $249,325
1,648 New
1,648 $233,000
Q4 2020

Feb 17, 2021
SELL
$102.03 - $184.62 $209,467 - $379,024
-2,053 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$93.53 - $163.34 $2,712 - $4,736
29 Added 1.43%
2,053 $200,000
Q2 2020

Aug 14, 2020
BUY
$126.3 - $176.56 $255,631 - $357,357
2,024 New
2,024 $316,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Cim Investment Management Inc Portfolio

Follow Cim Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cim Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email